Pulmonary hypertension secondary to interstitial lung disease

被引:1
|
作者
Shlobin, Oksana A. [1 ]
Nathan, Steven D. [1 ]
机构
[1] Inova Heart & Vasc Inst, Adv Lung Dis & Transplant Program, Falls Church, VA 22042 USA
关键词
catheterization; histiocytosis; hypertension; interstitial; Langerhans cell; lung diseases; lymphangioleiomyomatosis; pulmonary; pulmonary fibrosis; research design; sarcoidosis; scleroderma; Swan-Ganz; systemic; VENTRICULAR DIASTOLIC DYSFUNCTION; ARTERIAL-HYPERTENSION; SYSTEMIC-SCLEROSIS; SYSTOLIC PRESSURE; CONTROLLED-TRIAL; WALK DISTANCE; SARCOIDOSIS; FIBROSIS; HISTIOCYTOSIS; SILDENAFIL;
D O I
10.1586/ERS.11.11
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Interstitial lung diseases (ILDs) may be complicated by the development of pulmonary hypertension (PH), which is associated with worse functional impairment and a poorer prognosis. This article reviews the current state of knowledge on the prevalence, pathogenesis, diagnosis and prognosis of ILD-related PH. Whether the treatment of ILD-related PH changes clinical outcomes is currently unknown, but the current studies are summarized and the authors' perspective is offered.
引用
收藏
页码:179 / 189
页数:11
相关论文
共 50 条
  • [1] Pulmonary hypertension in interstitial lung disease
    Strange, C
    Highland, KB
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (05) : 452 - 455
  • [2] Pulmonary hypertension in interstitial lung disease
    Behr, J.
    Ryu, J. H.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1357 - 1367
  • [3] Pulmonary Hypertension in Interstitial Lung Disease
    Baldi, Bruno Guedes
    Souza, Rogerio
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 685 - 686
  • [4] Pulmonary hypertension in interstitial lung disease
    Polomis, David
    Runo, James R.
    Meyer, Keith C.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (05) : 462 - 469
  • [5] Pulmonary hypertension in interstitial lung disease
    Nathan, S. D.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 : 21 - 28
  • [6] Pulmonary hypertension in patients with interstitial lung disease
    Karampitsakos, Theodoros
    Tzouvelekis, Argyrios
    Chrysikos, Serafeim
    Bouros, Demosthenes
    Tsangaris, Iraklis
    Fares, Wassim H.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 50 : 38 - 46
  • [7] THE ANALYSIS OF INTERSTITIAL LUNG DISEASE WITH PULMONARY HYPERTENSION
    Shen, N.
    [J]. RESPIROLOGY, 2011, 16 : 324 - 324
  • [8] Exercise Pulmonary Hypertension in Interstitial Lung Disease
    Henry, K. J.
    Gargani, L.
    Sultan, S.
    Saggar, R.
    Bossone, E.
    Saggar, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Pulmonary hypertension due to interstitial lung disease
    King, Christopher S.
    Nathan, Steven D.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (05) : 459 - 467
  • [10] Pulmonary Hypertension Complicating Interstitial Lung Disease and COPD
    Shino, Michael Y.
    Lynch, Joseph P., III
    Saggar, Rajeev
    Abtin, Fereidoun
    Belperio, John A.
    Saggar, Rajan
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (05) : 600 - 619